
Jardiance, containing the active ingredient Empagliflozin, is an oral medication used to manage type 2 diabetes. It works by helping the kidneys remove excess glucose from the bloodstream, thus lowering blood sugar levels and improving glycemic control.
USD $39.43
Jardiance is an oral prescription medication used to help manage blood sugar levels in adults with Type 2 diabetes. It belongs to a class of drugs known as SGLT2 (Sodium-Glucose Co-Transporter-2) inhibitors, which work by preventing the kidneys from reabsorbing glucose back into the blood. Instead, excess glucose is excreted through urine, thereby lowering blood sugar levels.
In addition to its role in diabetes management, Jardiance is also approved to reduce the risk of cardiovascular death in adults with Type 2 diabetes and established heart disease. Studies have also shown its effectiveness in treating heart failure with reduced ejection fraction (HFrEF), making it a valuable option for heart health.
Jardiance is manufactured by Boehringer Ingelheim and Eli Lilly and Company and has been approved by regulatory agencies like the FDA (Food and Drug Administration) and EMA (European Medicines Agency).
Jardiance effectively reduces HbA1c levels, a critical marker for long-term blood sugar control. Clinical trials demonstrate that patients using Jardiance experience a statistically significant reduction in HbA1c compared to those on a placebo.
Unlike some diabetes medications that contribute to weight gain, Jardiance can promote modest weight loss by excreting excess glucose through urine. This is beneficial for overweight individuals with Type 2 diabetes.
Jardiance is the first SGLT2 inhibitor to show a significant reduction in the risk of cardiovascular death in individuals with Type 2 diabetes and heart disease. Studies like the EMPA-REG OUTCOME trial have demonstrated a 38% lower risk of cardiovascular-related mortality in Jardiance users compared to a placebo.
Jardiance also helps lower systolic blood pressure without significantly increasing the risk of hypotension, making it beneficial for patients with hypertension and diabetes.
Jardiance has been shown to slow the progression of kidney disease in patients with Type 2 diabetes, making it a promising option for individuals with diabetic nephropathy.
Increased Urination – Due to the mechanism of excreting glucose through urine.
Genital Yeast Infections – More common in women and uncircumcised men.
Urinary Tract Infections (UTIs) – Symptoms include burning sensation while urinating.
Mild Dehydration – Can lead to dizziness and thirst.
Ketoacidosis – A severe condition where blood becomes too acidic due to high ketone levels.
Fournier’s Gangrene – A rare but life-threatening infection of the genital area.
Severe Hypotension – Excessive blood pressure drop, leading to dizziness or fainting.
Kidney Injury – Although rare, Jardiance can cause kidney impairment in some patients.
Stay well-hydrated to prevent dehydration-related symptoms.
Maintain proper hygiene to reduce the risk of infections.
Monitor blood sugar levels and ketone levels if feeling unwell.
Individuals with Type 1 diabetes (Jardiance is not approved for this condition).
Those with severe kidney disease or on dialysis.
People with a history of severe ketoacidosis.
Jardiance may interact with:
Diuretics (can increase dehydration risk).
Insulin or sulfonylureas (can increase the risk of low blood sugar).
Blood pressure medications (can amplify hypotensive effects).
Jardiance is not recommended during pregnancy or while breastfeeding, as its effects on fetal development are not well studied.
| Medication | Drug Class | Blood Sugar Control | Weight Impact | Heart Benefits |
|---|---|---|---|---|
| Jardiance | SGLT2 Inhibitor | High | Weight Loss | Yes |
| Metformin | Biguanide | High | Weight Neutral | No |
| Rybelsus | GLP-1 Agonist | High | Weight Loss | Yes |
| Januvia | DPP-4 Inhibitor | Moderate | Weight Neutral | No |
Blood Sugar Control: Improvements can be seen within a few days to weeks.
HbA1c Reduction: Significant changes may take 2-3 months.
Cardiovascular Benefits: Studies show a reduction in heart-related risks after several months of consistent use.
Weight Loss: Typically observed over a few months of therapy.
Take one tablet daily in the morning, with or without food.
Drink plenty of water to avoid dehydration.
Do not crush or split the tablet.
| Strength | Recommended Use |
| 10mg | Initial dose for diabetes and heart failure. |
| 25mg | For patients requiring stronger glucose control. |
To ensure authenticity and safety, purchase Jardiance from licensed online pharmacies such as Waldrugmart, which offers prescription verification, customer support, and competitive pricing.
For additional details, refer to:
Official Jardiance Website (Manufacturer’s information)
FDA Medication Guide (Regulatory-approved prescribing information)
Diabetes Health Organizations like the American Diabetes Association (ADA) and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Jardiance is a powerful, Clinically Approved Pharmaceuticals medication that offers effective blood sugar control, cardiovascular protection, and kidney health benefits for individuals with Type 2 diabetes. Its dual benefits in managing diabetes and heart disease make it a preferred choice for many patients. Always consult with a healthcare provider to determine if Jardiance is the right medication for your specific needs.